We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic tes... read more Featured Products: More products

Download Mobile App




Multiplex PCR Panel Promises Faster Answers for GI Infections

By LabMedica International staff writers
Posted on 22 Jan 2026

Gastrointestinal infections are a major global health burden, with an estimated 179 million cases of acute gastroenteritis each year in the United States. More...

Caused by diverse pathogens—including bacteria, viruses, and parasites—these infections often present with overlapping symptoms such as diarrhea, abdominal pain, and fever, complicating diagnosis.

Rapid and accurate pathogen identification is essential for guiding treatment in high-risk patients and limiting outbreaks in healthcare and community settings. A new multiplex polymerase chain reaction (PCR) gastrointestinal panel has received U.S. Food and Drug Administration clearance, enabling single-sample detection of common bacterial, viral, and parasitic causes on Cepheid’s GeneXpert platform.

Cepheid’s Xpert GI Panel is a multiplex PCR assay that targets 11 clinically significant gastrointestinal pathogens from one patient specimen. The cartridge-based test runs on GeneXpert systems and is designed to streamline stool pathogen detection by consolidating multiple analyses into a single, automated workflow.

The assay processes stool collected in Cary-Blair transport media and reports results in approximately 74 minutes, with less than one minute of hands-oxn time. It opeartes on GeneXpert instrument systems equipped or upgraded with ten color modules, a configuration that supports concurrent detection of more than ten pathogens or biomarkers. By integrating sample preparation, amplification, and detection, the panel is intended to improve workflow efficiency for clinical laboratories.

The clearance comes as traditional stool culture workflows remain labor‑intensive and time‑consuming, with known limitations in identifying co‑infections or low‑abundance organisms. Multiplex molecular testing provides an alternative by simultaneously interrogating multiple targets, supporting faster clinical decisions.

Commenting on intended use, Connie Savor, MD, chief medical officer at Cepheid, said: “The Xpert GI Panel is designed to help healthcare providers identify the cause of infectious diarrhoea acquired in the community. By focusing on the most common causative pathogens, we’ve created a panel that balances clinical relevance with operational efficiency.”

Vitor Rocha, president of Cepheid, added: “Multiplex panels on the GeneXpert system deliver healthcare providers the versatility to do even more for their patients who need answers quickly — from targeted single-pathogen tests to broader multiplex tests on a single platform.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.